BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 17493361)

  • 1. [Clinical study on prognosis of acute leukemia subtypes Ly + AML and My + ALL].
    Liu B; Li R; Wu HJ; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):421-4. PubMed ID: 17493361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
    Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytomorphology of acute mixed leukemia].
    Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
    Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunophenotype of acute leukemia and its clinical significance].
    Zhu H; Niu T; Meng W; Xu C; Lei S
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):118-20. PubMed ID: 12599447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic classification used in typing of 68 cases of acute leukemias].
    Sun XL; Fang MY; Jiang F; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):39-41. PubMed ID: 16584588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and hematological correlates of aberrant immunophenotypic profiles in adult and pediatric acute myeloid leukemia at presentation.
    Sharma M; Varma N; Singh Sachdeva MU; Bose P; Varma S
    J Cancer Res Ther; 2020; 16(1):105-109. PubMed ID: 32362618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunophenotyping characteristics of biphenotypic acute leukemia and analysis of curative effect].
    Zhang JJ; Zhang N; Zhang XF; Shi Y; Wang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):317-20. PubMed ID: 21518479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse.
    Pui CH; Raimondi SC; Head DR; Schell MJ; Rivera GK; Mirro J; Crist WM; Behm FG
    Blood; 1991 Sep; 78(5):1327-37. PubMed ID: 1878594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CD34+ antigen expression relating to prognosis in acute myeloid leukemia].
    Li L; Wang R; Zhong D; Wen BZ; Abulaiti D; Lin ZQ; Jia M; Hao JP; Chen R; Guo XH; Wang L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):812-4. PubMed ID: 16277848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
    Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics and immunophenotypes of mixed-lineage acute leukemia].
    Li XL; Li R; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):636-9. PubMed ID: 17605883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study on role of CD34 in patients with Biphenotypic acute leukemia].
    Lu GJ; Song ZS; Zhang QM; Li PF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1226-9. PubMed ID: 25338562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical significance of lymphoid differentiation antigens in acute myeloid leukemia].
    Guo XH; Ni D
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):329-31. PubMed ID: 15228660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of co-expression of aberrant antigens in acute leukemia: a retrospective cohort study in Makah Al Mukaramah, Saudi Arabia.
    Abdulateef NA; Ismail MM; Aljedani H
    Asian Pac J Cancer Prev; 2014; 15(1):221-7. PubMed ID: 24528030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MIC categorization of acute lymphoblastic leukemia with myeloid surface antigen expression].
    Wu WL; Liang JY; Zhu MQ; Xue YQ; Chen ZX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):754-6. PubMed ID: 18457267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of acute biphenotypic leukemia.
    Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
    Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.